U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07200154) titled 'Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC' on Sept. 22.
Brief Summary: This is a single-arm, open-label, single-center phase II trial that will enroll 30 patients with limited-stage small-cell lung cancer to evaluate the safety and efficacy of adebrelimab combined with chemoradiotherapy followed by adebrelimab maintenance.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Limited-stage Small-cell Lung Cancer
Concurrent Chemoradiation Therapy
Intervention:
DRUG: Adebrelimab with concurrent chemoradiotherapy
Adebrelimab combined with chemotherapy and concurrent ra...